KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 12 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $35,793,199 | +8.5% | 65,976,000 | 0.0% | 1.15% | -4.8% |
| Q4 2023 | $32,987,982 | -19.4% | 65,976,000 | 0.0% | 1.21% | -6.3% |
| Q3 2023 | $40,943,996 | -4.8% | 65,976,000 | 0.0% | 1.29% | -8.0% |
| Q2 2023 | $43,016,352 | -15.9% | 65,976,000 | 0.0% | 1.41% | -16.7% |
| Q1 2023 | $51,148,346 | +3.6% | 65,976,000 | 0.0% | 1.69% | +2.0% |
| Q4 2022 | $49,369,841 | – | 65,976,000 | – | 1.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 8,000,000 | $5,215,000 | 9.09% |
| BRAIDWELL LP | 65,976,000 | $40,943,996 | 1.29% |
| Context Capital Management, LLC | 21,494 | $13,329 | 1.07% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 30,500,000 | $20,663,750 | 0.86% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 25,000,000 | $15,264,731 | 0.20% |
| DeepCurrents Investment Group LLC | 4,250,000 | $2,700,994 | 0.12% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,500,000 | $4,654,419 | 0.02% |
| Verition Fund Management LLC | 1,359 | $843,381 | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 6,500,000 | $4,033 | 0.01% |
| BLB&B Advisors, LLC | 75,000 | $45,794 | 0.00% |